Envoy Medical Income Statement (2021-2026) | COCH

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.06M0.02M0.08M0.06M0.08M0.10M0.06M0.07M0.06M0.04M0.05M0.08M0.04M0.07M0.04M
Cost of Revenue (Quarter) 0.11M0.54M0.17M0.16M0.40M0.51M0.15M0.50M0.39M-0.47M0.23M0.23M0.41M0.56M0.31M
Gross Profit (Quarter) -0.05M-0.52M-0.10M-0.10M-0.32M-0.42M-0.09M-0.43M-0.34M0.52M-0.18M-0.16M-0.36M-0.48M-0.27M
Operating items
Research & Development (Quarter) 0.94M1.44M1.93M2.15M1.85M3.06M2.36M2.59M2.76M2.47M2.75M2.48M2.70M4.55M3.64M
Selling, General & Administrative (Quarter) 0.81M0.45M1.38M1.84M1.03M3.02M2.10M1.59M1.69M1.45M1.82M2.07M2.44M1.60M1.88M
Other Operating Expenses (Quarter) 1.49M0.90M0.11M1.04M0.55M0.55M0.59M0.75M0.48M0.74M0.58M0.68M-5.18M0.59M0.61M0.31M-7.12M
Operating Expenses (Quarter) 1.49M0.90M1.85M2.93M3.85M4.54M3.46M6.82M4.94M4.92M5.03M4.59M-0.61M5.15M5.75M6.46M-1.60M
Operating Income (Quarter) -1.49M-0.90M-1.80M-2.91M-3.77M-4.48M-3.38M-6.72M-4.88M-4.85M-4.97M-4.55M-5.11M-5.07M-5.71M-6.38M-5.96M
EBIT (Quarter) -1.49M-0.90M-1.80M-2.91M-3.77M-4.48M-3.38M-6.72M-4.88M-4.85M-4.97M-4.55M-5.11M-5.07M-5.71M-6.38M-5.96M
Non-operating items
Interest & Investment Income (Quarter) 0.04M0.56M1.93M3.59M3.37M0.53M
Other Non Operating Income (Quarter) 0.57M-6.97M-9.38M9.27M0.05M0.11M-0.01M-0.01M0.01M-0.02M-0.01M-0.00M0.01M-0.02M0.01M
Non Operating Income (Quarter) 0.46M-8.57M0.10M-8.77M4.95M11.68M-1.39M0.91M-0.99M-1.53M-0.01M-0.62M0.01M-0.20M1.61M
Net income details
EBT (Quarter) 12.46M3.20M6.22M-1.15M1.56M-1.02M-3.38M-6.72M-4.92M-4.98M-5.24M-4.93M-5.60M-5.69M-6.18M-6.38M-5.96M
Tax Provisions (Quarter) 0.11M0.53M0.53M0.84M0.12M
Profit After Tax (Quarter) -1.87M-1.24M-1.34M-11.48M-13.25M-13.34M1.56M-4.89M-6.27M-3.95M-5.96M-4.62M-5.00M-5.69M-6.48M-6.59M-4.35M
Income from Continuing Operations (Quarter) 12.46M3.09M5.69M-1.68M0.72M-1.14M-3.38M-6.72M-4.92M-4.98M-5.24M-4.93M-5.60M-5.69M-6.18M-6.38M-5.96M
Consolidated Net Income (Quarter) 12.46M3.09M5.69M-1.68M0.72M-1.14M-3.38M-6.72M-4.92M-4.98M-5.24M-4.93M-5.60M-5.69M-6.18M-6.38M-5.96M
Income towards Parent Company (Quarter) 12.46M3.09M5.69M-1.68M0.72M-1.14M-3.38M-6.72M-4.92M-4.98M-5.24M-4.93M-5.60M-5.69M-6.18M-6.38M-5.96M
Preferred Dividend Payments (Quarter) -1.34M1.56M26.38M1.36M1.36M1.38M1.41M1.24M1.25M1.26M1.15M1.35M
Net Income towards Common Stockholders (Quarter) 2.49M10.62M-1.34M-11.48M-13.25M-13.25M1.40M-6.24M-7.63M-5.31M-7.34M-7.69M-6.24M-6.94M-7.75M-7.74M-5.70M
Additional items
EPS (Basic) (Quarter) 0.230.06-0.13-1.130.02-1.310.13-0.08-0.41-0.29-0.39-0.40-0.29-0.32-0.35-0.26-0.08
EPS (Weighted Average and Diluted) (Quarter) 0.230.06-0.13-1.13-1.31-0.080.13-0.08-0.41-0.29-0.39-0.40-0.29-0.32-0.35-0.26-0.08
Shares Outstanding (Weighted Average) (Quarter) 10.59M42.50M42.50M10.12M10.12M31.89M10.12M10.15M12.30M18.60M18.60M18.61M0.66M21.33M21.38M21.85M2.07M68.93M
Shares Outstanding (Diluted Average) (Quarter) 35.22M42.50M42.50M10.12M10.12M10.12M10.12M11.22M12.30M18.60M18.60M18.62M18.79M21.33M21.36M21.85M23.26M68.93M
EBITDA (Quarter) -1.49M-0.90M-1.34M-11.48M-13.25M-13.25M1.56M-4.90M-6.27M-3.95M-5.96M-4.62M-4.99M-5.69M-6.48M-6.59M-4.35M
Interest Expenses (Quarter) 0.04M0.13M0.26M0.38M0.49M0.62M0.47M
Tax Rate (Quarter) 3.39%8.58%-46.43%53.97%-11.92%